Rodman & Renshaw downgraded its rating on Insulet PODD to Market Underperform. At the moment, the rating agency has a price target on the company's stock unchanged at $18. On Friday, PODD closed the day at $22.51. Its shares lost 2.22% of their value in today's pre-market trading to stand around $22.01.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
